Chapter 26 principles of pharmacology

Option C: Phenytoin does not undergo N-oxidation in its metabolism; instead, it is primarily metabolized through hydroxylation and glucuronidation pathways. This distinguishes it from the other drugs listed, which do involve N-oxidation as part of their metabolic processes.

Option A: Dapsone is metabolized via N-oxidation, which is a significant pathway for its biotransformation, leading to the formation of active metabolites.

Option B: Meperidine undergoes N-oxidation as part of its metabolic pathway, contributing to the formation of its active metabolite, normeperidine.

Option D: Chlorpheniramine is also metabolized through N-oxidation, which plays a role in its pharmacokinetics and the generation of metabolites.

Takeaways: Understanding the metabolic pathways of drugs, such as N-oxidation, is crucial for predicting drug interactions and side effects; for instance, phenytoin's metabolism does not involve this pathway, highlighting its unique pharmacokinetic profile. More details on drug metabolism can be found in this NIH resource.

Option A: The oral bioavailability of a drug is a measure of the extent to which it enters the systemic circulation after administration. This concept is crucial for understanding how much of the drug reaches the bloodstream and is available for therapeutic effect.

Option B: Changing the excipient after oral administration does not influence the drug's bioavailability, as excipients are typically involved in the formulation before administration, not afterward.

Option C: While the bioavailability can be calculated using the area under the plasma concentration time curve (AUC), this option inaccurately describes the definition by not clearly stating that it compares the AUC of oral versus intravenous administration.

Option D: Hepatic CYP450 induction may affect drug metabolism and clearance but does not inherently reduce bioavailability; in fact, it may increase the metabolism of certain drugs, potentially lowering their systemic availability.

Takeaways: Understanding oral bioavailability is essential for assessing how much of a drug enters systemic circulation after administration, which requires careful consideration of factors like formulation and metabolism. For more information on this concept, refer to bioavailability and its clinical implications.

Option A: Sorbitol is added to soft gelatin capsules to enhance their elasticity and plasticity, allowing for better encapsulation of liquid formulations. This property is crucial for maintaining the integrity and performance of the capsule during storage and administration.

Option B: Povidone serves primarily as a binder and solubilizing agent in pharmaceutical formulations, but it does not contribute to the elasticity or plasticity of gelatin capsules.

Option C: Polyethylene glycol is used as a plasticizer in some formulations, but it is not typically used to enhance the properties of soft gelatin capsules specifically.

Option D: Lactose is a filler or diluent in tablet formulations and does not have any role in modifying the elasticity or plasticity of soft gelatin capsules.

Takeaways: Sorbitol is essential for enhancing the elasticity of soft gelatin capsules, which is critical for their performance and stability; understanding this helps in the formulation of effective drug delivery systems, especially when considering the properties of excipients in pharmaceutical formulations.

Option C: Type III hypersensitivity reactions are characterized by the formation of immune complexes that can lead to inflammation and tissue damage. In this case, the patient's symptoms of low-grade fever, rash, and muscle and joint pain after long-term sulfonamide therapy suggest an immune complex-mediated reaction, which aligns with Type III hypersensitivity. This type of reaction typically occurs days to weeks after exposure to the antigen, consistent with the timeline presented.

Option A: Type I hypersensitivity involves immediate allergic reactions mediated by IgE antibodies, such as anaphylaxis or allergic rhinitis, which do not match the delayed onset and symptoms described in this scenario.

Option B: Type II hypersensitivity is mediated by IgG or IgM antibodies against cell surface antigens, leading to cytotoxic effects. This type typically presents with hemolytic anemia or thrombocytopenia, which are not indicated by the patient's symptoms.

Option D: Type IV hypersensitivity is a delayed-type reaction mediated by T cells, often presenting with contact dermatitis or graft-versus-host disease. The symptoms described do not align with this mechanism, as they are more indicative of immune complex involvement.

Takeaways: Type III hypersensitivity reactions involve immune complex formation leading to symptoms such as fever, rash, and joint pain, particularly after prolonged exposure to certain medications like sulfonamides, which requires awareness of drug reactions and patient monitoring during therapy.

Option A: Methotrexate inhibits dihydrofolate reductase, which synthesizes tetrahydrofolate from dihydrofolate, thereby interfering with DNA synthesis and cell replication. This mechanism is crucial in its use as an antimetabolite in cancer therapy and autoimmune diseases.

Option B: The toxicity of high doses of methotrexate can be mitigated by administering leucovorin (folinic acid) shortly after methotrexate, not 24 hours later, to provide a source of reduced folate for normal cells.

Option C: Methotrexate is primarily excreted by the kidneys, not the bile, making renal function a critical consideration in dosing and toxicity management.

Option D: Chronic treatment with methotrexate can lead to liver toxicity, including fibrosis, but cirrhosis is not a guaranteed outcome and requires careful monitoring of liver function.

Takeaways: Methotrexate's mechanism of action involves the inhibition of dihydrofolate reductase, which is essential for DNA synthesis, and understanding its pharmacokinetics, including renal excretion, is vital for safe administration and monitoring, as detailed in MedlinePlus on methotrexate.

Option D: Both B & C accurately describe the limitations of nonselective MAOIs as antidepressants due to their high toxicity and the potential to interact with many foods and drugs, leading to serious adverse effects such as hypertensive crises and serotonin syndrome.

Option A: Low efficacy does not apply, as nonselective MAOIs can be effective for certain patients, but their use is limited primarily due to safety concerns.

Option B: High toxicity is a significant issue, but it is not the sole reason for the limited use of nonselective MAOIs; the potential for food and drug interactions also plays a critical role.

Option C: While the potential to interact with many foods and drugs is a valid concern, it alone does not encompass the full scope of limitations, which also includes toxicity.

Takeaways: Nonselective MAOIs have limited use as antidepressants due to their high toxicity and potential to interact with many foods and drugs, necessitating careful patient education regarding dietary restrictions to prevent serious complications.

Option B: Spare receptors will be detected if the intracellular effect of drug-receptor interaction lasts longer than the drug-receptor interaction itself, indicating that not all receptors need to be occupied to elicit a full response. This concept is crucial in pharmacology, as it explains how drugs can achieve maximal effects even when not all receptors are activated.

Option A: Spare receptors are not sequestered in the cytoplasm in the absence of a drug; rather, they are available on the cell surface and can be activated when needed.

Option C: While spare receptors can influence the efficacy of a drug-receptor system, they do not directly determine maximal efficacy; rather, they contribute to the overall response when fewer receptors are occupied.

Option D: Spare receptors do not activate the effector machinery of the cell without a drug; they require a ligand to initiate the signaling cascade, even if not all receptors are occupied.

Takeaways: Understanding spare receptors is essential in pharmacology, as they allow for a full response from a drug even when not all receptors are engaged, which requires knowledge of receptor theory and drug action for effective therapeutic strategies.

Option C: Exhibits anti-H. pylori activity. Ranitidine has been shown to have some efficacy against H. pylori, making it a viable option in combination therapy for peptic ulcer disease. This characteristic distinguishes it from famotidine, which does not have this specific activity against H. pylori.

Option A: Preferred in liver dysfunction. Ranitidine is not preferred in liver dysfunction; famotidine is often chosen due to its safer profile in patients with hepatic impairment.

Option B: More potent antisecretory. Famotidine is actually more potent than ranitidine in terms of antisecretory effects, making this statement inaccurate.

Option D: Exhibits less inhibitory effects on hepatic microsomal enzyme system. Both ranitidine and famotidine have minimal effects on hepatic enzymes, but famotidine is generally considered to have a more favorable profile regarding enzyme inhibition.

Takeaways: Ranitidine's ability to exhibit anti-H. pylori activity is a key characteristic that differentiates it from famotidine, which does not have this effect and is often used in conjunction with antibiotics for treatment. Understanding these distinctions is crucial for effective pharmacological management of peptic ulcer disease, especially in relation to H. pylori treatment guidelines.

Option A: Docusate is a stool softener that helps to relieve constipation by increasing the water content in the stool, making it easier to pass. This is particularly beneficial for patients using morphine, as opioids like morphine commonly cause constipation due to their effects on gastrointestinal motility.

Option B: Codeine is an opioid that can exacerbate constipation rather than relieve it, as it shares similar constipating effects with morphine.

Option C: Loperamide is an antidiarrheal medication that works by slowing gut movement and is not indicated for treating constipation; it can worsen the condition in patients already experiencing constipation from opioids.

Option D: Diphenoxylate is also an antidiarrheal agent that slows intestinal motility and is not appropriate for treating constipation, as it can further complicate the issue.

Takeaways: Docusate serves as an effective treatment for opioid-induced constipation by softening stools, which is crucial for patient comfort and bowel health, especially in those on opioids like morphine. For more information on managing opioid-induced constipation, refer to MedlinePlus on opioid use and constipation.

Option D: An emulsion base is the correct classification for vanishing cream, which typically consists of a mixture of water and oil, allowing for a smooth application and effective moisture retention on the skin. This formulation enhances skin hydration while providing a protective barrier, making it suitable for various dermatological uses.

Option A: A water-soluble base does not accurately describe vanishing cream, as it contains both water and oil components, rather than being solely water-based.

Option B: An oleaginous base refers to a formulation that is primarily oil-based, which does not align with the characteristics of vanishing cream that incorporates both water and oil.

Option C: An absorption base is designed to absorb water into an oil base, which is not the primary function of vanishing cream, as it is formulated as an emulsion rather than focusing on absorption.

Takeaways: Emulsion bases, like vanishing cream, combine water and oil to create a product that hydrates and protects the skin, requiring understanding of formulation types in dermatology for effective application.

Option B: Aqueous hydrolysis does not represent a mechanism of drug permeation, as it refers to a chemical reaction involving water that breaks down compounds rather than a process by which drugs pass through biological membranes.

Option A: Aqueous diffusion is a recognized mechanism of drug permeation, allowing drugs to move through aqueous environments, such as bodily fluids, via concentration gradients.

Option C: Lipid diffusion is a critical mechanism for drug permeation, enabling lipophilic drugs to traverse cell membranes composed of lipid bilayers effectively.

Option D: Pinocytosis or endocytosis are active transport mechanisms that facilitate the uptake of substances into cells, thus serving as valid pathways for drug permeation.

Takeaways: Understanding the mechanisms of drug permeation, such as aqueous diffusion and lipid diffusion, is essential for pharmacology, as it influences drug absorption and bioavailability; for more details on these processes, see drug absorption mechanisms.

Option D: High plasma proteins binding tends to reduce a drug's volume of distribution by limiting its availability in the extravascular space. When a drug binds extensively to plasma proteins, less of it is free to distribute into tissues, resulting in a smaller volume of distribution. This characteristic is crucial in pharmacokinetics as it influences drug efficacy and safety.

Option A: Low ionization at physiological pH increases a drug's ability to cross cell membranes, enhancing its distribution into tissues rather than reducing it.

Option B: High lipid solubility allows a drug to easily penetrate cell membranes and accumulate in tissues, which increases its volume of distribution.

Option C: High tissue binding increases the volume of distribution as the drug accumulates in various tissues rather than remaining in the plasma.

Takeaways: Understanding how high plasma protein binding reduces a drug's volume of distribution is essential for predicting drug behavior in the body, as it requires consideration of pharmacokinetic principles when assessing therapeutic outcomes.

Option B: Have a low risk of cardiotoxicity and stroke is false as selective COX-2 inhibitors, while designed to reduce gastrointestinal side effects, have been associated with an increased risk of cardiovascular events, including myocardial infarction and stroke. This risk necessitates careful patient selection and monitoring.

Option A: Are associated with low risk of gastric ulceration is true; selective COX-2 inhibitors primarily spare the gastric mucosa, leading to a lower incidence of ulcers compared to non-selective NSAIDs.

Option C: Nephrotoxicity is a serious adverse effect is true; COX-2 inhibitors can lead to renal impairment, particularly in patients with pre-existing kidney conditions or those on diuretics.

Option D: Celecoxib should not be given to patients with sulfonamide allergy is true; celecoxib contains a sulfonamide moiety, which can trigger allergic reactions in susceptible individuals.

Takeaways: Selective COX-2 inhibitors, while beneficial for reducing gastric ulcer risk, are associated with an increased risk of cardiovascular events, necessitating careful patient selection and monitoring for cardiovascular safety in NSAID use.